ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 98 filers reported holding ENDOLOGIX INC in Q1 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $871,000 | -56.5% | 1,215,671 | +15.9% | 0.00% | – |
Q3 2018 | $2,004,000 | -67.1% | 1,049,262 | -2.4% | 0.00% | -100.0% |
Q2 2018 | $6,088,000 | +36.7% | 1,075,587 | +2.2% | 0.00% | +100.0% |
Q1 2018 | $4,454,000 | -20.2% | 1,052,855 | +1.0% | 0.00% | 0.0% |
Q4 2017 | $5,580,000 | +18.0% | 1,042,712 | -1.6% | 0.00% | 0.0% |
Q3 2017 | $4,729,000 | -11.9% | 1,060,173 | -4.1% | 0.00% | -50.0% |
Q2 2017 | $5,369,000 | -29.5% | 1,104,943 | +5.0% | 0.00% | 0.0% |
Q1 2017 | $7,617,000 | +27.7% | 1,052,188 | +0.9% | 0.00% | 0.0% |
Q4 2016 | $5,965,000 | -55.4% | 1,042,892 | -0.1% | 0.00% | -50.0% |
Q3 2016 | $13,361,000 | +4.4% | 1,043,773 | +1.6% | 0.00% | 0.0% |
Q2 2016 | $12,804,000 | +57.0% | 1,027,724 | +7.8% | 0.00% | +33.3% |
Q1 2016 | $8,158,000 | -13.0% | 953,174 | +0.6% | 0.00% | 0.0% |
Q4 2015 | $9,377,000 | -14.4% | 947,132 | +6.0% | 0.00% | -25.0% |
Q3 2015 | $10,959,000 | -7.8% | 893,852 | +15.4% | 0.00% | 0.0% |
Q2 2015 | $11,883,000 | -19.3% | 774,618 | -10.2% | 0.00% | 0.0% |
Q1 2015 | $14,733,000 | +12.1% | 863,046 | +0.4% | 0.00% | 0.0% |
Q4 2014 | $13,147,000 | +54.4% | 859,807 | +7.0% | 0.00% | +33.3% |
Q3 2014 | $8,517,000 | -28.2% | 803,460 | +3.1% | 0.00% | -25.0% |
Q2 2014 | $11,857,000 | +2.4% | 779,607 | -13.3% | 0.00% | 0.0% |
Q1 2014 | $11,578,000 | -28.0% | 899,587 | -2.4% | 0.00% | -20.0% |
Q4 2013 | $16,082,000 | +10.7% | 922,164 | +2.4% | 0.01% | 0.0% |
Q3 2013 | $14,534,000 | +29.7% | 900,492 | +6.7% | 0.01% | +25.0% |
Q2 2013 | $11,207,000 | – | 843,914 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|